Target intelligence / Profile preview

Caspase 16, pseudogene (CASP16P)

Target
CASP16P
Molecular classification
Other (pseudogene; originally from the *enzyme* class: cysteine-dependent aspartate-directed proteases/caspases, but now a non-functional remnant)
01

Overview

Caspase 16, pseudogene (CASP16P), is a non-functional genomic remnant of the ancestral caspase-16 gene in humans. Due to a frameshift mutation, it is unable to encode a catalytically active protease. While functional caspase-16 is present in some other mammals and likely shares biological roles with the apoptotic and inflammatory caspase family, the human gene is transcribed but does not produce an active protein. As such, CASP16P is not considered a protein-coding gene, therapeutic target, or clinically relevant biomarker, and there are no drugs targeting this locus. In many other mammals, caspase-16 is a functional cysteine protease involved in cell death or inflammation, similar to caspase-14 and -15, but in humans the gene is a pseudogene due to inactivating mutation. CASP16P sometimes appears in gene lists but should not be confused with active caspases or counted as a molecular target for drugs or therapies. Pseudogenes can have regulatory or evolutionary significance but, as in this case, do not encode functional proteins.

Other names
CASP16 (previous HGNC symbol)
02

Mechanism of action

None (does not code for an active molecule)

03

Biological functions

None in human (in contrast to other caspases, functional caspase-16 in other mammals may be involved in apoptosis or inflammation)
04

Disease associations

Other (no known direct disease involvement in humans since it is not functional; loss/gain of pseudogenes may have evolutionary impact)
05

Safety considerations

None (No clinical targeting or relevance due to non-functionality)
06

Interacting drugs

None (no drug can interact with a non-functional pseudogene)
07

Biomarkers

None (CASP16P is not used in clinical biomarker panels)

Beyond the preview

Go deeper on Caspase 16, pseudogene (CASP16P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caspase 16, pseudogene (CASP16P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call